Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03376373 · ClinicalTrials.gov registry record · NA
Neurotherapy to Promote Emotion Recognition in Autism
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03376373 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 28 participants.
The verdict
NCT03376373, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, more prevalent than previously thought and heterogeneous in expression, though uniformly characterized by severe social disability. The social disability that defines ASD pervades other areas of adaptive behavior, is predictive of secondary mental health problems, and adversely affects long-term outcome. Although ASD is a chronic condition, there has been little research on interventions for adults with ASD. This study proposes to first establish the neural plasticity of specific brain mechanisms underlying difficulties with facial emotion recognition, a core deficit believed to be pivotal in the behavioral expression of ASD-social disability. The investigators will then develop a novel, computer-based intervention using real-time feedback, to the user, to ameliorate emotion recognition deficits.
Interventions
- BEHAVIORAL neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03376373
The ClinicalTrials.gov registry entry for NCT03376373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which neurofeedback is the first listed.
NCT03376373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03376373 about?
NCT03376373 is a clinical study titled "Neurotherapy to Promote Emotion Recognition in Autism". Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, more prevalent than previously thought and heterogeneous in expression, though uniformly characterized by severe social disability. The social disability that defines ASD pervades other areas of adaptive behavior, is predictive of seco...
What is the current status of trial NCT03376373?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-09-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03376373?
The interventions under investigation include: neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03376373?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.